Skip to main content

Table 1 Clinical and biochemical characteristics and cardiac fat compartments in the study population

From: Cardiac steatosis and left ventricular function in men with metabolic syndrome

  MetS present (n = 37) MetS absent (n = 38) p
Age (years) 47 ± 6 40 ± 8 <0.001
Body mass index (kg/m2) 30.9 (24.2-42.5) 23.4 (17.6-29.8) <0.001
Waist circumference (cm) 107.0 (94.0-135.0) 87.0 (71.0-93.5) <0.001
Height (cm) 180 ± 6 180 ± 6 0.665
Current smokers (N, %) 13 (35) 4 (10) 0.014
Systolic blood pressure (mmHg) 132 ± 14 115 ± 10 <0.001
Diastolic blood pressure (mmHg) 88 ± 9 74 ± 6 <0.001
Total cholesterol (mmol/L) 5.25 ± 0.74 4.38 ± 0.80 <0.001
Low-density lipoprotein cholesterol (mmol/L) 3.25 ± 0.71 2.52 ± 0.67 <0.001
High-density lipoprotein cholesterol (mmol/L) 1.02 ± 0.26 1.50 ± 0.40 <0.001
Triglycerides (mmol/L) 2.20 (0.65-6.26) 0.72 (0.35-1.57) <0.001
fP-glucose (mmol/L) 5.8 (4.6-6.9) 5.0 (4.4-6.0) <0.001
fS-insulin (mU/L) 9.3 (3.3-36.9) 2.9 (0.9-7.7) <0.001
HOMA-IR index 2.6 (0.8-8.0) 0.6 (0.2-2.0) <0.001
Myocardial triglyceride content (%) 0.90 (0.31-2.33) 0.43 (0.14-1.39) <0.001
Epicardial fat (mm2) 838 (385-1753) 518 (251-1129) <0.001
Pericardial fat (mm2) 1905 (615-6131) 562 (66-1582) <0.001
  1. Data are expressed as means (± SD), medians (range), or frequencies (%). HOMA-IR, the homeostasis model assessment insulin resistance.